skip to main
|
skip to sidebar
biosink
8.25.2007
Venture Capital Basics � SlideShare
Venture Capital Basics � SlideShare
:
Newer Post
Older Post
Home
Blog Archive
►
2013
(14)
►
05/05 - 05/12
(1)
►
04/07 - 04/14
(9)
►
03/31 - 04/07
(1)
►
03/10 - 03/17
(3)
►
2010
(4)
►
06/13 - 06/20
(1)
►
01/31 - 02/07
(2)
►
01/10 - 01/17
(1)
►
2009
(22)
►
09/20 - 09/27
(2)
►
09/06 - 09/13
(1)
►
08/09 - 08/16
(1)
►
08/02 - 08/09
(1)
►
07/12 - 07/19
(1)
►
05/10 - 05/17
(2)
►
04/19 - 04/26
(5)
►
04/12 - 04/19
(1)
►
04/05 - 04/12
(7)
►
03/01 - 03/08
(1)
►
2008
(290)
►
12/28 - 01/04
(2)
►
12/21 - 12/28
(4)
►
12/14 - 12/21
(2)
►
11/23 - 11/30
(1)
►
10/26 - 11/02
(5)
►
10/19 - 10/26
(5)
►
10/12 - 10/19
(55)
►
10/05 - 10/12
(1)
►
09/28 - 10/05
(1)
►
09/21 - 09/28
(45)
►
09/14 - 09/21
(3)
►
08/31 - 09/07
(5)
►
08/24 - 08/31
(20)
►
08/17 - 08/24
(3)
►
08/10 - 08/17
(1)
►
08/03 - 08/10
(3)
►
07/13 - 07/20
(1)
►
07/06 - 07/13
(2)
►
06/29 - 07/06
(13)
►
06/15 - 06/22
(2)
►
06/08 - 06/15
(2)
►
06/01 - 06/08
(2)
►
05/25 - 06/01
(7)
►
05/18 - 05/25
(7)
►
05/11 - 05/18
(1)
►
04/27 - 05/04
(9)
►
04/20 - 04/27
(22)
►
04/13 - 04/20
(11)
►
04/06 - 04/13
(20)
►
03/30 - 04/06
(4)
►
03/23 - 03/30
(1)
►
03/16 - 03/23
(1)
►
03/09 - 03/16
(1)
►
02/24 - 03/02
(3)
►
02/17 - 02/24
(10)
►
02/10 - 02/17
(5)
►
02/03 - 02/10
(2)
►
01/27 - 02/03
(3)
►
01/13 - 01/20
(4)
►
01/06 - 01/13
(1)
▼
2007
(1218)
►
12/16 - 12/23
(4)
►
12/02 - 12/09
(5)
►
11/25 - 12/02
(4)
►
11/18 - 11/25
(22)
►
11/11 - 11/18
(31)
►
11/04 - 11/11
(10)
►
10/28 - 11/04
(4)
►
10/21 - 10/28
(15)
►
10/14 - 10/21
(31)
►
10/07 - 10/14
(85)
►
09/30 - 10/07
(129)
►
09/23 - 09/30
(23)
►
09/16 - 09/23
(98)
►
09/09 - 09/16
(116)
►
09/02 - 09/09
(52)
►
08/26 - 09/02
(57)
▼
08/19 - 08/26
(52)
Venture Capital Basics � SlideShare
Science Business: The Promise, the Reality, and th...
Enbrel: The Sting of Success
Bayer & Millennium Pharmaceuticals: Success Based ...
Survivor Scios: Reality Biotech--The Anatomy of a ...
Connetics and Relaxin
Bio-Tech, Inc.
Race to Develop Human Insulin
Kevin Simpson
ImmuLogic Pharmaceutical Corp. (A): March 1991
ImmuLogic Pharmaceutical Corp. (Abridged)
ALZA and Bio-Electro Systems (A): Technological an...
Genzyme Corp.: Strategic Challenges with Ceredase
Chiron Corp.
Genzyme Corp.: A Financing History
Repligen Corp.: January 1992
Aberlyn Capital Management: July 1993
Alpha-Beta Technology, Inc.: Pioneering Carbohydra...
Kevin Simpson at Haemonetics, Video
The Money Connection—Understanding VC Networks Pub...
Banking Deregulation, Financing Constraints and En...
Report from China: The New Entrepreneurs Published...
Cephalon, Inc.
The Pharma Giants: Ready for the 21st Century?
Gene Research, the Mapping of Life and the Global ...
Novartis: Betting on Life Sciences
Medi-Cult: Pricing a Radical Innovation
Monsanto and the Global Water Treatment Industry
Strategic Deal Making at Millennium Pharmaceuticals
When the Boss Won't Budge (HBR Case Study and Comm...
Transforming Life, Transforming Business: The Life...
Biogen Unchained
Monsanto's Genetically Modified Organisms: The Bat...
Pharmacyclics: Financing Research & Development
Abgenix and the XenoMouse
DNA: Handle with Care
Robert Shapiro and Monsanto
Diagnostic Genomics
Centagenetix (A): Building a Business Model for Ge...
Proteome Systems Ltd.
Perlegen Sciences
Calgene, Inc.
E.I. du Pont de Nemours and Co.: The Conoco Split-...
The Life Sciences Revolution: A Technical Primer
Four VCs on Evaluating Opportunities — HBS Working...
International Financial Integration and Entreprene...
Surviving Success: When Founders Must Go — HBS Wor...
NeuroTherapy Ventures: Catalyzing Neurologic Innov...
Genzyme: Engineering the Market for Orphan Drugs
In Vivo to in Vitro to in Silico: Coping with Tida...
What Price Tranquility? $100 Million - Forbes.com
White Paper
►
07/29 - 08/05
(40)
►
07/22 - 07/29
(173)
►
07/15 - 07/22
(24)
►
07/08 - 07/15
(10)
►
05/06 - 05/13
(7)
►
04/29 - 05/06
(76)
►
04/22 - 04/29
(150)
